Philadelphia Phillies closer José Alvarado has been suspended for 80 games without pay by the MLB after testing positive for exogenous testosterone, a banned performance-enhancing substance under the league's Joint Drug Prevention and Treatment Program. The suspension, announced on May 18, 2025, takes immediate effect and renders Alvarado ineligible for the remainder of the regular season and any potential postseason play.

At the age of 29, Alvarado has made himself one of the best players on the bullpen for the Phillies this season. He is posting a 2.70 ERA, 1.20 WHIP, and 25 strikeouts over 20 innings pitched. He leads the team with seven saves and five holds, contributing significantly to the Phillies' 27-18 record as of the suspension announcement.

The timing of the suspension is particularly damaging, as the team is contending for the National League East title and a playoff berth. This is definitely a bad news for a team that has strong World Series aspirations and may well be hurting their chances now more than ever.

A Tough Break

The Phillies expressed disappointment over Alvarado's violation but reaffirmed their commitment to MLB's drug policy. In a statement, the team emphasized the importance of maintaining the integrity of the game and supporting the league's efforts to eliminate performance-enhancing substances.

“It’s disappointing for sure,” Phillies president of baseball operations Dave Dombrowski said Sunday morning at Citizens Bank Park. “There’s no question about that. We’ve had other issues come up at various times. I end up treating it like an injury because you need to replace somebody for 80 games and then hopefully into the postseason.”

With Alvarado sidelined, the Phillies face increased pressure on an already underperforming bullpen. Relievers such as Jordan Romano and Orion Kerkering have yet to meet expectations, and the team may need to explore trade opportunities to bolster their relief corps. However, with many teams in contention for playoff spots, acquiring quality bullpen help may prove challenging.

Under MLB's drug policy, a first positive test for a banned substance results in an 80-game suspension without pay. A second offense leads to a 162-game suspension, and a third offense results in a lifetime ban from the league. Players are not eligible for postseason play during their suspension, regardless of when it concludes.

Alvarado has the right to appeal the suspension, but unless the appeal is successful, the penalty will stand. If upheld, the suspension will serve as a significant setback in his career and the Phillies' season.

Losing Alvarado

Alvarado is in the final year of a three-year, $21.5 million contract extension signed in February 2023, which includes a $9 million club option for the 2026 season. The suspension raises questions about his future with the team, as the Phillies will need to assess the impact of the violation on his performance and reputation.

José Alvarado's suspension marks a significant development in the 2025 MLB season, highlighting the ongoing challenges teams face in maintaining compliance with league policies. This is, after all, not the first time that a player has been suspended for drug use as well.

For the Phillies, the loss of their top reliever presents both a tactical and emotional hurdle as they navigate the remainder of the season without one of their most reliable pitchers. The team's response and any subsequent roster moves will be closely scrutinized as they aim to remain competitive in the National League East.